Candidate gene
Marker
| vimentin methylation predicted poor overall survival independent of race, subtype, stage, nodal status, or metastatic disease and holds promise as a new prognostic biomarker for breast cancer patient | |
changes in VIM and FBLN1 methylation levels in cell-free DNA (cfDNA) are associated with Hepatocellular carcinoma (HCC) and could represent useful plasma-based biomarkers | |
positive VIM expression was shown to predict patients' relapse and poor outcome regarding patients' overall survival in laryngeal squamous cell carcinoma | Therapy target
| | |